An Innovative Funding Model for Biotech Companies

This webcast features: Joe Payne, president & COO & Jeff Wolf, founder & CEO, Scorpius BioManufacturing.

Too many promising biologic candidates are stalled without critical early-stage funding. Grant funding often falls short of the capital needed for pre-clinical and phase 1 manufacturing, but dilutive capital is hard to secure without positive early-stage data.

In this webinar, learn about a hybrid model for capital-efficient access to cGMP manufacturing, process development, and analytical services for early-stage biotech companies through in-kind equity investment.

Hear from Scorpius’ president and founder about why this US biologics CDMO was inspired to develop an innovative funding model to support innovative biotech companies.

Thank you for your interest in this webcast. You may submit your request to view the webcast, and you will receive a confirmation email with log-in details.